Lithium Controlled-Release and Extended-Release Tablets and Oxymetazoline Topical application
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Oxymetazoline Topical application and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: oxymetazoline topical
Brand name: Rhofade
Synonyms: Oxymetazoline topical, Oxymetazoline (Topical)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Oxymetholone
- Lithium Controlled-Release and Extended-Release Tablets-Oxymorphone
- Lithium Controlled-Release and Extended-Release Tablets-Oxymorphone Extended-Release Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Oxymorphone Hydrochloride
- Lithium Controlled-Release and Extended-Release Tablets-Oxymorphone Injection
- Lithium Controlled-Release and Extended-Release Tablets-Oxymorphone Tablets
- Oxymetazoline Topical application-Lithium ER
- Oxymetazoline Topical application-Lithium Oral Solution
- Oxymetazoline Topical application-Lithium Salts
- Oxymetazoline Topical application-Lithium Syrup and Oral Solution
- Oxymetazoline Topical application-Lithobid
- Oxymetazoline Topical application-Lithostat